Covered recipient · General Payments record
EMILY A SONGER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2022–2024
$864.20
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $255.56 | 16 |
| Education | $84.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $133.78 | 4 |
| Organon LLC | $62.50 | 5 |
| CooperSurgical, Inc. | $45.56 | 2 |
| SHIELD THERAPEUTICS INC | $22.98 | 1 |
| Novo Nordisk AS | $19.38 | 1 |
| PFIZER INC. | $18.69 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $18.49 | 1 |
| Meditrina | $9.65 | 1 |
| Channel Medsystems, Inc. | $9.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $14.27 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139287514 | CMS |
| Astellas Pharma US Inc | $84.99 | 02/05/2024 | Education | Undisputed | 01/23/2026 | 1139343700 | CMS |
| Astellas Pharma US Inc | $17.25 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139395909 | CMS |
| Astellas Pharma US Inc | $17.27 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139432072 | CMS |
| Channel Medsystems, Inc. | $9.52 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067444800 | CMS |
| CooperSurgical, Inc. | $22.25 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150787178 | CMS |
| CooperSurgical, Inc. | $23.31 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150787186 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $18.49 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154690093 | CMS |
| Meditrina | $9.65 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154266678 | CMS |
| Novo Nordisk Inc | $19.38 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097457515 | CMS |
| Organon Llc | $14.45 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136198168 | CMS |
| Organon Llc | $12.17 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136198170 | CMS |
| Organon Llc | $6.34 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136198172 | CMS |
| Organon Llc | $11.18 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136198174 | CMS |
| Organon Llc | $18.36 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136314921 | CMS |
| PFIZER INC. | $18.69 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131636992 | CMS |
| SHIELD THERAPEUTICS INC | $22.98 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150120180 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.